
Charles Sande
@charlesjsande
ID: 956193475422248960
24-01-2018 15:54:24
145 Tweet
283 Followers
314 Following


VOTE NOW!! Nchafatso Obonyo has been named a finalist in the "Forty Under 40 Africa" Awards in the Science, Technology and Innovation category. 🎉🎉🎉 Public vote counts towards 20% of the scoring and closes 28 Feb! MORE INFO 👉bit.ly/voteobonyo thecommongoodau @MetroNorthHHS


It's an incredible day for structure-based vaccine design, and I'm thrilled to see our prefusion RSV F antigen get approved as the first RSV vaccine. Still more work to do to reduce the RSV disease burden, but this will help! Congrats Barney Graham, MD, PhD! cnn.com/2023/05/03/hea…


Crazy!!! Fluorescence microscopy has now achieved Angstrom resolution! Jungmann Lab Max Planck Institute of Biochemistry (MPIB) could even resolve single DNA base-pairs. Works also to resolve individual NPC proteins in cells. Amazing work today nature! nature.com/articles/s4158…


1/13 Excited to share our study describing a 161 gene signature able to simultaneously classify 18 paediatric infectious & inflammatory diseases using multi-class supervised #Machinelearning. Out in Med by Cell Press after a few years in the making 📰 cell.com/med/fulltext/S…

I'm a Professor!!!!!! (thought about more mature ways of saying it, but this worked) Thanks to everyone Imperial College London Imperial Medicine Imperial Department of Infectious Disease for all the support along the way: mentors, team, colleagues And of course Charlie Weller


Congratulations, DR. Alex Macharia. Incredible defence of your PhD thesis to pass WITHOUT CORRECTIONS! And to your supervisors led by Prof Tom Williams! alexmacharia Tom Williams IDeAL, Africa KEMRI-Wellcome


New long term efficacy data on #typhoid conjugate #vaccines are out The Lancet. - 1 dose of vaccine - >4 years of follow up - in children 9mo - 12yrs - 78.3% efficacy - Millions of children potentially protected Take on Typhoid UMSOM Center for Vaccine Dev. & Global Health Malawi Liverpool Wellcome Programme thelancet.com/journals/lance…


Mohamed Wehliye, MBS GREAT 👏🏽👏🏽 They should even be MORE. We can’t have people living in SLUMS in 2023 while some live in OPULENCE. The BUBBLE should BURST. Prices DROP, people MOVE UP respective to incomes so that SLUMS stop making sense as an OPTION

New paper out from the CJ lab! Have a look if you are interested in knowing more about SARS-CoV-2 omicron mouse models!! Great collaborative study Patricia Ogger wendybarclay NHLI


Promising news: for the first time, World Health Organization (WHO) has prequalified a maternal RSV vaccine to protect infants. Now, we are working on how to deliver it in lower-income countries, where 99% of RSV deaths occur to protect those most at risk. rb.gy/vti4ox

Happy to share a recently published review from our group making the case for better #ARTaccess for #LMICs and #Ghana Published in Frontiers in Epidemiology frontiersin.org/journals/epide…


Shingles vax appears to prevent dementia! Our Nature paper is first of many from my group to show this. We use a really neat natural experiment to provide causal (not just correlational!) evidence. Paper: nature.com/articles/s4158…; video (👏 Maya Adam MD): bit.ly/4ciRfLh
